BofA Securities Adjusts Price Target on Amicus Therapeutics to $17 From $16, Maintains Buy Rating
BofA Securities Adjusts Price Target on Amicus Therapeutics to $17 From $16, Maintains Buy Rating
美国银行证券将Amicus Therapeutics的目标股价从16美元调整至17美元,维持买入评级
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册